We are live on
!
Find out more
NC
nVerses Capital Portfolio holdings
AUM
$65M
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$41.7M
AUM Growth
+$5.68M
(+16%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
97.23%
Top 10 Holdings %
Top 10 Hldgs %
5.55%
Holding
604
New
604
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Methode Electronics
MEI
|
+$276K |
| 2 |
Dropbox
DBX
|
+$272K |
| 3 |
Independent Bank
INDB
|
+$249K |
| 4 |
Compass Minerals
CMP
|
+$248K |
| 5 |
Liberty Broadband Class C
LBRDK
|
+$245K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.03% |
| 2 | Technology | 16.08% |
| 3 | Industrials | 14.73% |
| 4 | Consumer Discretionary | 13.42% |
| 5 | Healthcare | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Tarsus Pharmaceuticals
TARS
$3.07B
| $69.1K | 0.17% |
+1,900
| New | +$55.9K |
|
|
RNAM
227
DELISTED
Avidity Biosciences
RNAM
| $68.9K | 0.17% |
+2,700
| New | +$42.3K |
|
|
SEMR
228
DELISTED
Semrush
SEMR
| $67.6K | 0.16% |
+5,100
| New | +$61.4K |
|
229
Merck
MRK
$334B
| $66K | 0.16% |
+500
| New | +$61.6K |
|
|
FOLD
230
DELISTED
Amicus Therapeutics
FOLD
| $66K | 0.16% |
+5,600
| New | +$71.6K |
|
231
D.R. Horton
DHI
$40.8B
| $65.8K | 0.16% |
+400
| New | +$60K |
|
232
TG Therapeutics
TGTX
$7.34B
| $65.4K | 0.16% |
+4,300
| New | +$68.5K |
|
233
Sarepta Therapeutics
SRPT
$1.95B
| $64.7K | 0.16% |
+500
| New | +$61.2K |
|
234
Globus Medical
GMED
$11.5B
| $64.4K | 0.15% |
+1,200
| New | +$64.5K |
|
|
ATSG
235
DELISTED
Air Transport Services Group
ATSG
| $63.3K | 0.15% |
+4,600
| New | +$66.3K |
|
236
AMC Global Media
AMCX
$485M
| $63.1K | 0.15% |
+5,200
| New | +$78.9K |
|
237
Pennant Group
PNTG
$1.34B
| $62.8K | 0.15% |
+3,200
| New | +$53.9K |
|
238
Riley Exploration Permian
REPX
$786M
| $62.7K | 0.15% |
+1,900
| New | +$47.5K |
|
239
Abercrombie & Fitch
ANF
$4.84B
| $62.7K | 0.15% |
+500
| New | +$57K |
|
240
Ramaco Resources Class A
METC
$667M
| $62.3K | 0.15% |
+3,824
| New | +$67.8K |
|
|
ESGR
241
DELISTED
Enstar Group
ESGR
| $62.2K | 0.15% |
+200
| New | +$57.3K |
|
|
VSXY
242
Victoria's Secret
VSXY
$7.24B
| $62K | 0.15% |
+3,200
| New | +$78.5K |
|
|
PRFT
243
DELISTED
Perficient Inc
PRFT
| $61.9K | 0.15% |
+1,100
| New | +$72K |
|
244
Pilgrim's Pride
PPC
$6.57B
| $61.8K | 0.15% |
+1,800
| New | +$54K |
|
245
Netflix
NFLX
$326B
| $60.7K | 0.15% |
+1,000
| New | +$56.4K |
|
|
BASE
246
DELISTED
Couchbase
BASE
| $60.5K | 0.15% |
+2,300
| New | +$59.8K |
|
247
Corcept Therapeutics
CORT
$12.1B
| $60.5K | 0.15% |
+2,400
| New | +$56.7K |
|
248
Standard Motor Products
SMP
$877M
| $60.4K | 0.14% |
+1,800
| New | +$65.9K |
|
249
Bumble
BMBL
$359M
| $60.2K | 0.14% |
+5,300
| New | +$67.6K |
|
250
Trane Technologies
TT
$105B
| $60K | 0.14% |
+200
| New | +$54.3K |
|
Similar funds
PFO
1M
ILCM
SGOM
RC
HPCM
CP
YEPX
nVerses Capital's Q1 2024 Portfolio in Review
As of Q1 2024, nVerses Capital held 604 positions worth $41.7M, up 16% from $36M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
nVerses Capital deployed $40.5M of net new capital in Q1 2024, opening 604 new positions. Its largest new stake was Methode Electronics: 14,600 shares worth $178K.
By sector, the portfolio is most concentrated in Financials at 18% of assets, followed by Technology and Industrials.
- nVerses Capital's largest Q1 2024 buy was Methode Electronics: 14,600 shares worth $178K.
- nVerses Capital's ten largest holdings make up 5.5% of its $41.7M portfolio in Q1 2024.
- nVerses Capital opened 604 new positions and closed 0 in Q1 2024.
- nVerses Capital's portfolio value rose 16% quarter-over-quarter to $41.7M.
Based on nVerses Capital's 13F filing for Q1 2024, filed 25 Apr 2024.